Lead Product(s) : Chlordiazepoxide,Amitriptyline Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : MedQuímica Indústria Farmacêutica
Deal Size : Undisclosed
Deal Type : Acquisition
Lupin's Brazil Subsidiary Acquires 9 Brands From Bausch Health
Details : As part of the transaction, MedQuímica will acquire rights to nine products including Limbitrol, Melleril and Dalmadorm for Central Nervous System related conditions, Bacrocin, Glyquin, Solaquin, Oxipelle™ and Efurix as topical oncological treatments.
Product Name : Limbitrol
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
November 28, 2022
Lead Product(s) : Chlordiazepoxide,Amitriptyline Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : MedQuímica Indústria Farmacêutica
Deal Size : Undisclosed
Deal Type : Acquisition